참고문헌
- Acebedo AR, Amor EC, Jacinto SD (2014). Apoptosis-inducing activity of HPLC fraction from Voacanga globosa (Blanco) Merr. on the human colon carcinoma cell. Asian Pac J Cancer Prev, 15, 617-22. https://doi.org/10.7314/APJCP.2014.15.2.617
- Chapline C, Cottom J, Tobin H, et al (1998). A major, transformation-sensitive PKC-binding protein is also a PKC substrate involved in cytoskeletal remodeling. J Biol Chem, 273, 19482-99. https://doi.org/10.1074/jbc.273.31.19482
- Choi MC, Jong HS, Kim TY, et al (2004). AKAP12/Gravin is inactivated by epigenetic mechanism in human gastric carcinoma and shows growth suppressor activity. Oncogene, 23, 7095-103. https://doi.org/10.1038/sj.onc.1207932
- Daoud SS, Munson PJ, Reinhold W, et al (2003). Impact of p53 knockout and topotecan treatment on gene expression profiles in human colon carcinoma cells: a pharmacogenomic study. Cancer Res, 63, 2782-93.
- Gelman IH (2010). Emerging Roles for SSeCKS/Gravin/AKAP12 in the control of cell proliferation, cancer malignancy, and barriergenesis. Genes Cancer, 1, 1147-56. https://doi.org/10.1177/1947601910392984
- Gelman IH (2002). The role of SSeCKS/gravin/AKAP12 scaffolding proteins in the spaciotemporal control of signaling pathways in oncogenesis and development. Front Biosci, 7, 1782-97. https://doi.org/10.2741/gelman
- Gordon T, Grove B, Loftus JC, et al (1992). Molecular cloning and prelimnary haracteriztion of a novel cytoplasmic antigen recognized by myasthenia gravis sera. J Clin Invest, 90, 992-9. https://doi.org/10.1172/JCI115976
- Jalali MM, Heidarzadeh A, Zavarei MJ, Sarmast H (2011). p53 overexpression impacts on the prognosis of laryngeal squamous cell carcinomas. Asian Pac J Cancer Prev, 12, 1731-4.
- Jin Z, Hamilton JP, Yang J, et al (2008). Hypermethylation of the AKAP12 promoter is a biomarker of Barrett’s-associated esophageal neoplastic progression. Cancer Epidemiol Biomarkers Prev, 17, 111-7. https://doi.org/10.1158/1055-9965.EPI-07-0407
- Kerns BJ, Jordan PA, Moore MB, et al (1992). p53 overexpression in formalin-fixed, paraffin-embedded tissue detected by immunohistochemistry. J Histochem Cytochem, 40, 1047-51. https://doi.org/10.1177/40.7.1607637
- Kim GP, Colangelo LH, Wieand HS, et al (2007). National Cancer Institute. Prognostic and predictive roles of highdegree microsatellite instability in colon cancer: a National Cancer Institute–National Surgical Adjuvant Breast and Bowel Project Collaborative Study. J Clin Oncol, 25, 767-72. https://doi.org/10.1200/JCO.2006.05.8172
- Li HY, Zhang Y, Cai JH, Bian HL (2013). MicroRNA-451 inhibits growth of human colorectal carcinoma cells via downregulation of Pi3k/Akt pathway. Asian Pac J Cancer Prev, 14, 3631-4. https://doi.org/10.7314/APJCP.2013.14.6.3631
- Lin X, Nelson PJ, Frankfort B, et al (1995). Isolation and characterization of a novel mitogenic regulatory gene, 322, which is transcriptionally suppressed in cells transformed by src and ras. Mol Cell Biol, 15, 2754-62.
- Lin X, Tombler E, Nelson PJ, Ross M, Gelman IH (1996). A novel src- and ras-suppressed protein kinase C substrate associated with cytoskeletal architecture. J Biol Chem, 271, 28430-8. https://doi.org/10.1074/jbc.271.45.28430
- Lin X, Nelson P, Gelman IH (2000). SSeCKS, a major protein kinase C substrate with tumor suppressor activity, regulates G(1)-->S progression by controlling the expression and cellular compartmentalization of cyclin D. Mol Cell Biol, 20, 7259-72. https://doi.org/10.1128/MCB.20.19.7259-7272.2000
- Liu W, Guan M, Hu T, Gu X, Lu Y (2011). Re-expression of AKAP12 inhibits progression and metastasis potential of colorectal carcinoma in vivo and in vitro. PLoS One, 6, 24015. https://doi.org/10.1371/journal.pone.0024015
- Menezes HL, Juca MJ, Gomes EG, et al (2010). Analysis of the immunohistochemical expressions of p53, Bcl-2 and Ki-67 in colorectal adenocarcinoma and their correlations with the prognostic factors. Arq Gastroenterol, 47, 141-7. https://doi.org/10.1590/S0004-28032010000200005
- Mitra PS, Basu NK, Owens IS. (2009) Src supports UDPglucuronosyltransferase-2B7 detoxification of catechol estrogens associated with breast cancer. Biochem Biophys Res Commun, 382, 651-6. https://doi.org/10.1016/j.bbrc.2009.03.054
- Nauert JB, Klauck TM, Langeberg LK, Scott JD (1997). Gravin, an autoantigen recognized by serum from myasthenia gravis patients, is a kinase scaffold protein. Curr Biol, 7, 52-62. https://doi.org/10.1016/S0960-9822(06)00027-3
- Sasaki H, Kunimatsu M, Fujii Y, et al (2001). Autoantibody to gravin is expressed more strongly in younger and nonthymomatous patients with myasthenia gravis. Surgery Today, 31, 1036-7. https://doi.org/10.1007/s005950170020
- Shih M, Lin F, Scott JD, Wang HY, Malbon CC (1999). Dynamic complexes of beta2-adrenergic receptors with protein kinases and phosphatases and the role of gravin. J Biol Chem, 274, 1588-95. https://doi.org/10.1074/jbc.274.3.1588
- Tessema M, Belinsky SA (2008). Mining the epigenome for methylated genes in lung cancer. Proc Am Thorac Soc, 5, 806-10. https://doi.org/10.1513/pats.200805-045TH
- Vermeulen K, Berneman ZN, Van Bockstaele DR (2003). Cell cycle and apoptosis. Cell Prolif, 36, 165-75. https://doi.org/10.1046/j.1365-2184.2003.00267.x
- Yildirim M, Paydas S, Tanriverdi K, et al (2007). Gravin gene expression in acute leukaemias: clinical importance and review of the literature. Leuk Lymphoma, 48, 1167-72. https://doi.org/10.1080/10428190701377055
- Yildirim M, Suren D, Goktas S, et al (2012). The predictive role of Bcl-2 expression in operable locally advanced or metastatic gastric carcinoma. J BUON, 17, 106-9.
- Yoon DK, Jeong CH, Jun HO, et al (2007). AKAP12 induces apoptotic cell death in human fibrosarcoma cells by regulating CDKI-cyclin D1 and caspase-3 activity. Cancer Lett, 254, 111-8. https://doi.org/10.1016/j.canlet.2007.02.017
- Zhao DP, Ding XW, Peng JP, Zheng YX, Zhang SZ (2005). Prognostic significance of Bcl-2 and p53 expression in colorectal carcinoma. J Zhejiang Univ Sci B, 6, 1163-9. https://doi.org/10.1631/jzus.2005.B1163
- Zhu JH, Hong DF, Song YM, et al (2013). Suppression of cellular apoptosis susceptibility (CSE1L) inhibits proliferation and induces apoptosis in colorectal cancer cells. Asian Pac J Cancer Prev, 14, 1017-21. https://doi.org/10.7314/APJCP.2013.14.2.1017